Table 2.
Activin A targets in brain injury.
| activin A-related brain injury | Targets/mechanism | References |
|---|---|---|
| Hypoxic-ischemic brain damage | Follistatin/BMP-4, Act A/Smad pathway, p-Smad3/CHOP/caspase-12, LC3II/Beclin1, JNK1/p38 |
Tian et al., 2014 Nakajima et al., 2014 Guo et al., 2014 Wang et al., 2016a Xue et al., 2017. |
| Focal cerebral ischemia | Act A/Smad pathway | Mukerji et al., 2009 Hiratochi et al., 2007 Xue et al., 2016. |
| Ischemic tolerance | Act RII/JNK1/Smad3/Smad4 | Xue et al., 2016 Wang et al., 2016b. |
| Cerebral hemorrhage | activin A binding protein | Nicolas et al., 2017 Ebert et al., 2006. |
| Premature infant brain injury | Acvr2a/Acvr2b, IL-10 |
Dillenburg et al., 2018 González-Domínguez et al., 2016 Petrakou et al., 2013. |
| Sepsis encephalopathy | TNF-α/IL-6/IL-1, caspase-1/IL-1β/ IL-8 |
Tania et al., 2014 Petrakou et al., 2013 Asashima et al., 1991. |
Act A, activin A; Act RII, activin A receptor type II; Acvr2a/Acvr2b, activin A receptor type 2a/2b; BMP-4, bone morphogenetic protein 4; CHOP, C/EBP homologous protein; IL, interleukin; JNK1, c-Jun N-terminal kinase 1; LC3II, microtubule-associated protein light chain 3 II; TNF-α, tumor necrosis factor alpha.